Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab

Saved in:
Bibliographic Details
Published inInternational journal of dermatology Vol. 59; no. 10; pp. 1294 - 1295
Main Authors Criado, Paulo R., Criado, Roberta F. J., Pincelli, Thais P., Yoshimoto, Thais A., Naufal, Gabriela G. A., Abdalla, Beatrice M. Z.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.10.2020
John Wiley and Sons Inc
Subjects
Anti-Allergic Agents - administration & dosage
Chronic Urticaria - drug therapy
Chronic Urticaria - immunology
Correspondence
COVID-19
COVID-19 - complications
COVID-19 - diagnosis
COVID-19 - immunology
COVID-19 - virology
Female
Humans
Immunoglobulin E
Immunotherapy
Injections, Subcutaneous
Lung - diagnostic imaging
Middle Aged
Monoclonal antibodies
Omalizumab - administration & dosage
SARS-CoV-2 - immunology
SARS-CoV-2 - isolation & purification
Symptom Flare Up
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Urticaria
Online AccessGet full text

Cover

More Information
Bibliography:Conflict of interest: P.R.C and R.F.J.C. have received grants from Novartis SA for intellectual support and lectures.
Funding source: None.
ISSN:0011-9059
1365-4632
DOI:10.1111/ijd.15134